Search

Your search keyword '"Adang, Laura"' showing total 365 results

Search Constraints

Start Over You searched for: Author "Adang, Laura" Remove constraint Author: "Adang, Laura"
365 results on '"Adang, Laura"'

Search Results

1. Correlation between age of onset and genotype with systemic symptomatology in Aicardi Goutières Syndrome

2. TREX1 is required for microglial cholesterol homeostasis and oligodendrocyte terminal differentiation in human neural assembloids

6. Systemic complications of Aicardi Goutières syndrome using real-world data

7. Developmental delay can precede neurologic regression in early onset metachromatic leukodystrophy

8. Consensus guidelines for the monitoring and management of metachromatic leukodystrophy in the United States

9. Longitudinal natural history studies based on real-world data in rare diseases: Opportunity and a novel approach

11. Newborn screening in metachromatic leukodystrophy – European consensus-based recommendations on clinical management

12. Pulmonological issues

13. SARS-CoV-2 mRNA-based vaccines in the Aicardi Goutières Syndrome

15. Hematologic abnormalities in Aicardi Goutières Syndrome

16. Gene therapy in advanced metachromatic leukodystrophy: tempering expectations.

17. Determination of Health Concepts in β-Propeller Protein–Associated Neurodegeneration.

20. Modified Delphi procedure-based expert consensus on endpoints for an international disease registry for Metachromatic Leukodystrophy: The European Metachromatic Leukodystrophy initiative (MLDi)

21. Nonverbal Cognitive Skills in Children With Aicardi Goutières Syndrome

25. Nucleotide metabolism, leukodystrophies, and CNS pathology.

27. Phenotypic and Imaging Spectrum Associated With WDR45

30. Systemic Complications and Natural History of Aicardi Goutières Syndrome (P6-8.001)

32. Characterization of Fine Motor and Visual Motor Skills in Aicardi-Goutières Syndrome

33. Effective Gene Therapy for Metachromatic Leukodystrophy Achieved with Minimal Lentiviral Genomic Integrations

34. Hematopoietic stem cell gene therapy improves outcomes in a clinically relevant mouse model of Multiple Sulfatase Deficiency

35. Development of a rigorous approach for retrospective natural history studies in leukodystrophies

36. Validation of GMFC-MLD scale as a measure of gross motor function in metachromatic leukodystrophy

38. A phase 2 study assessing TAK-611150 mg intrathecal weekly in patients with late-infantile metachromatic leukodystrophy (SHP611–201; EMBOLDEN) compared to matched historical control data from children with late-infantile MLD (GLIA-MLD)

41. Inventory of current practices regarding hematopoietic stem cell transplantation in metachromatic leukodystrophy in Europe and neighboring countries

42. Framework for Multistakeholder Patient Registries in the Field of Rare Diseases: Focus on Neurogenetic Diseases

43. Framework for Multistakeholder Patient Registries in the Field of Rare Diseases:Focus on Neurogenetic Diseases

44. Newborn screening in metachromatic leukodystrophy – European consensus-based recommendations on clinical management

45. Systemic Complications of Aicardi Goutières Syndrome Using Real World Data

47. Biochemical signatures of disease severity in multiple sulfatase deficiency

50. Revised consensus statement on the preventive and symptomatic care of patients with leukodystrophies

Catalog

Books, media, physical & digital resources